Pfizer Opens Oncology R&D Center in San Diego
Pfizer opened an oncology research and development center in May of 2026 on the Torrey Heights campus in San Diego. Designed by DGA, the 230,000-sf facility will accelerate the creation of groundbreaking medicines for gastrointestinal, hematologic, thoracic, breast, and genitourinary cancers. Supporting a broad pipeline of innovative biologics, the leading-edge complex features specialized laboratories dedicated to small-molecule drugs, antibody-drug conjugates (ADCs), and multispecific antibodies.